A Study Utilizing Escitalopram in Glioma Patients
Phase 2
20
about 8.5 years
19+
1 site in NE
What this study is about
Researchers are testing whether escitalopram, an oral medication, can improve cognitive function in adults with newly diagnosed grade IV glioma. The trial will last for approximately 3100 days and involve around 20 participants.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Escitalopram Oral Capsules
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
escitalopram (SSRI; increases serotonin availability)
oral (Oral Tablet)
Primary: Change in Psycho-social Functions - PROMIS Neuro-QoL Item Bank v1.0 - Anxiety, Change in Psycho-social Functions - PROMIS Neuro-QoL Item Bank v1.0 - Depression, Change in Psycho-social Functions - PROMIS Neuro-QoL Item Bank v1.0 - Fatigue
Neurology